212 related articles for article (PubMed ID: 28904123)
1. Unveiling the Peptide Motifs of HLA-C and HLA-G from Naturally Presented Peptides and Generation of Binding Prediction Matrices.
Di Marco M; Schuster H; Backert L; Ghosh M; Rammensee HG; Stevanović S
J Immunol; 2017 Oct; 199(8):2639-2651. PubMed ID: 28904123
[TBL] [Abstract][Full Text] [Related]
2. Nonclassical HLA-G molecules are classical peptide presenters.
Diehl M; Münz C; Keilholz W; Stevanović S; Holmes N; Loke YW; Rammensee HG
Curr Biol; 1996 Mar; 6(3):305-14. PubMed ID: 8805247
[TBL] [Abstract][Full Text] [Related]
3. Large scale mass spectrometric profiling of peptides eluted from HLA molecules reveals N-terminal-extended peptide motifs.
Escobar H; Crockett DK; Reyes-Vargas E; Baena A; Rockwood AL; Jensen PE; Delgado JC
J Immunol; 2008 Oct; 181(7):4874-82. PubMed ID: 18802091
[TBL] [Abstract][Full Text] [Related]
4. A viral, transporter associated with antigen processing (TAP)-independent, high affinity ligand with alternative interactions endogenously presented by the nonclassical human leukocyte antigen E class I molecule.
Lorente E; Infantes S; Abia D; Barnea E; Beer I; García R; Lasala F; Jiménez M; Mir C; Morreale A; Admon A; López D
J Biol Chem; 2012 Oct; 287(42):34895-34903. PubMed ID: 22927436
[TBL] [Abstract][Full Text] [Related]
5. Unsupervised HLA Peptidome Deconvolution Improves Ligand Prediction Accuracy and Predicts Cooperative Effects in Peptide-HLA Interactions.
Bassani-Sternberg M; Gfeller D
J Immunol; 2016 Sep; 197(6):2492-9. PubMed ID: 27511729
[TBL] [Abstract][Full Text] [Related]
6. Naturally processed HLA class I bound peptides from c-myc-transfected cells reveal allele-specific motifs.
Harris PE; Colovai A; Liu Z; Dalla Favera R; Suciu-Foca N
J Immunol; 1993 Dec; 151(11):5966-74. PubMed ID: 8245441
[TBL] [Abstract][Full Text] [Related]
7. Peptide Binding to HLA-E Molecules in Humans, Nonhuman Primates, and Mice Reveals Unique Binding Peptides but Remarkably Conserved Anchor Residues.
Ruibal P; Franken KLMC; van Meijgaarden KE; van Loon JJF; van der Steen D; Heemskerk MHM; Ottenhoff THM; Joosten SA
J Immunol; 2020 Nov; 205(10):2861-2872. PubMed ID: 33020145
[TBL] [Abstract][Full Text] [Related]
8. Preimplantation Factor (PIF) Promotes HLA-G, -E, -F, -C Expression in JEG-3 Choriocarcinoma Cells and Endogenous Progesterone Activity.
Hakam MS; Miranda-Sayago JM; Hayrabedyan S; Todorova K; Spencer PS; Jabeen A; Barnea ER; Fernandez N
Cell Physiol Biochem; 2017; 43(6):2277-2296. PubMed ID: 29073617
[TBL] [Abstract][Full Text] [Related]
9. A comprehensive analysis of constitutive naturally processed and presented HLA-C*04:01 (Cw4)-specific peptides.
Schittenhelm RB; Dudek NL; Croft NP; Ramarathinam SH; Purcell AW
Tissue Antigens; 2014 Mar; 83(3):174-9. PubMed ID: 24397554
[TBL] [Abstract][Full Text] [Related]
10. Uncovering the peptide-binding specificities of HLA-C: a general strategy to determine the specificity of any MHC class I molecule.
Rasmussen M; Harndahl M; Stryhn A; Boucherma R; Nielsen LL; Lemonnier FA; Nielsen M; Buus S
J Immunol; 2014 Nov; 193(10):4790-802. PubMed ID: 25311805
[TBL] [Abstract][Full Text] [Related]
11. Peptidomic analysis of type 1 diabetes associated HLA-DQ molecules and the impact of HLA-DM on peptide repertoire editing.
Zhou Z; Reyes-Vargas E; Escobar H; Chang KY; Barker AP; Rockwood AL; Delgado JC; He X; Jensen PE
Eur J Immunol; 2017 Feb; 47(2):314-326. PubMed ID: 27861808
[TBL] [Abstract][Full Text] [Related]
12. Identification and characterisation of peptide binding motifs of six autoimmune disease-associated human leukocyte antigen-class I molecules including HLA-B*39:06.
Eichmann M; de Ru A; van Veelen PA; Peakman M; Kronenberg-Versteeg D
Tissue Antigens; 2014 Oct; 84(4):378-88. PubMed ID: 25154780
[TBL] [Abstract][Full Text] [Related]
13. Class I MHC-peptide interaction: structural and functional aspects.
Ruppert J; Kubo RT; Sidney J; Grey HM; Sette A
Behring Inst Mitt; 1994 Jul; (94):48-60. PubMed ID: 7998914
[TBL] [Abstract][Full Text] [Related]
14. Revisiting the arthritogenic peptide theory: quantitative not qualitative changes in the peptide repertoire of HLA-B27 allotypes.
Schittenhelm RB; Sian TC; Wilmann PG; Dudek NL; Purcell AW
Arthritis Rheumatol; 2015 Mar; 67(3):702-13. PubMed ID: 25418920
[TBL] [Abstract][Full Text] [Related]
15. Editing of the HLA-DR-peptide repertoire by HLA-DM.
Kropshofer H; Vogt AB; Moldenhauer G; Hammer J; Blum JS; Hämmerling GJ
EMBO J; 1996 Nov; 15(22):6144-54. PubMed ID: 8947036
[TBL] [Abstract][Full Text] [Related]
16. A roadmap for HLA-A, HLA-B, and HLA-C peptide binding specificities.
Chelvanayagam G
Immunogenetics; 1996; 45(1):15-26. PubMed ID: 8881033
[TBL] [Abstract][Full Text] [Related]
17. Toward the prediction of class I and II mouse major histocompatibility complex-peptide-binding affinity: in silico bioinformatic step-by-step guide using quantitative structure-activity relationships.
Hattotuwagama CK; Doytchinova IA; Flower DR
Methods Mol Biol; 2007; 409():227-45. PubMed ID: 18450004
[TBL] [Abstract][Full Text] [Related]
18. Allele-specific peptide ligand motifs of HLA-C molecules.
Falk K; Rötzschke O; Grahovac B; Schendel D; Stevanović S; Gnau V; Jung G; Strominger JL; Rammensee HG
Proc Natl Acad Sci U S A; 1993 Dec; 90(24):12005-9. PubMed ID: 8265661
[TBL] [Abstract][Full Text] [Related]
19. Pocketcheck: updating the HLA class I peptide specificity roadmap.
Huyton T; Ladas N; Schumacher H; Blasczyk R; Bade-Doeding C
Tissue Antigens; 2012 Sep; 80(3):239-48. PubMed ID: 22803829
[TBL] [Abstract][Full Text] [Related]
20. Several HLA alleles share overlapping peptide specificities.
Sidney J; del Guercio MF; Southwood S; Engelhard VH; Appella E; Rammensee HG; Falk K; Rötzschke O; Takiguchi M; Kubo RT
J Immunol; 1995 Jan; 154(1):247-59. PubMed ID: 7527812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
